You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HNSCC dose expansion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022

Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Tucson, Arizona
  • +16 more
Nov 15, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in London (VB10.16, Pembrolizumab)

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • London, United Kingdom
    East and North Hertfordshire NHS Trust Mount Vernon Hospital
Aug 24, 2023

Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

Not yet recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +3 more
  • (no location specified)
Jul 24, 2022

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 19, 2022

Advanced Solid Tumor Trial (STI-7349, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Aug 3, 2023

Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)

Active, not recruiting
  • Advanced Solid Tumors
  • Macquarie, New South Wales, Australia
  • +6 more
Dec 1, 2022

Unresectable or Metastatic Advanced Solid Tumors Trial (WTX212A)

Not yet recruiting
  • Unresectable or Metastatic Advanced Solid Tumors
  • (no location specified)
Sep 6, 2023

Advanced Solid Tumors Trial in Beijing (WJB001)

Not yet recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023

Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)

Recruiting
  • Solid Tumor, Adult
  • DT-9081 - dose escalation
  • DT-9081 - expansion
  • Anderlecht, Belgium
  • +3 more
Jan 5, 2023

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)

Not yet recruiting
  • Recurrent or Metastatic Solid Tumors
  • Recombinant Anti-EpCAM-CD3 Antibody Injection
  • (no location specified)
Oct 17, 2023

Advanced Solid Tumor Trial (NB002)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 29, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Solid Advanced Tumor, Lymphoma Trial in Belgium, France (OSE-279 100mg, OSE-279 300mg, OSE-279 500mg)

Recruiting
  • Solid Advanced Tumor
  • Lymphoma
  • OSE-279 100mg
  • +2 more
  • Anderlecht, Belgium
  • +5 more
Feb 27, 2023

Myeloid Diseases Trial (DFV890)

Not yet recruiting
  • Myeloid Diseases
  • (no location specified)
Nov 11, 2022

Tumors Malignant Trial in Shanghai (AK117)

Active, not recruiting
  • Neoplasms Malignant
  • Shanghai, Shanghai, China
    FuDan University Shanghai Cancer Center
Oct 8, 2022

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Cancer Trial in Singapore (YS-0N-001)

Recruiting
  • Cancer
  • YS-0N-001
  • Singapore, Singapore
    National University Cancer Institute Singapore
Dec 20, 2022

Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

Recruiting
  • Malignant Solid Tumor
  • +5 more
  • GEN1042
  • +8 more
  • San Diego, California
  • +27 more
Dec 24, 2022